… BRAF V600E mutation with molecular markers and clinicopathological parameters. After
adjustments for age, sex, and tumor size, the BRAF V600E mutation … metastasis, tumor stage III/…

… This meta-analysis demonstrates that the BRAF V600E mutation is closely related to the
high-risk clinicopathological factors and poorer outcome of PTC. The results obtained here …

… To investigate the mutant status of BRAF gene and analyze its relationship to epidemiological
risk factors and clinical outcomes among patients with papillary thyroid cancer (PTC) in the …

… further test the hypothesis that the BRAF V600E mutation is a prognostic indicator for PTC.
The study determined the prevalence of the BRAF V600E mutation in conventional PTC tissue …

… that BRAF mutations may play a critical role in the carcinogenesis of papillary carcinoma of
the thyroid. … and spectrum of BRAF mutations in thyroid carcinoma and their relation to RAS …

… T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 2008;113:247-255. …
between STAT1 activity and BRAF mutations in papillary thyroid carcinomas. J Surg Oncol …

… BRAF mutation represents the most common oncogenic event in sporadic papillary thyroid
cancer (PTC). There are, however, significant discrepancies regarding the overall frequency …

… The objective of this study was to investigate the relationship of the BRAF mutation with …
of the thyroid gland and who had undergone BRAF mutation tests of their thyroid cancer tissue. …

… This study tests the prevalence of BRAF V600E mutation in thyroid cancer patients in Indian
… analyzed 140 thyroid tumor specimens for BRAF gene mutation at codon 600 using mutant-…

… BRAF mutations are closely associated with … in papillary thyroid cancer. Accordingly,
aggressive treatment should be considered for papillary thyroid cancer patients with BRAF mutation. …